ABCZY - Abcam Plc

Other OTC - Other OTC Delayed Price. Currency in USD
17.1225
+0.0500 (+0.29%)
At close: 1:18PM EDT
Stock chart is not supported by your current browser
Previous Close17.0725
Open17.1225
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range17.1225 - 17.1225
52 Week Range12.0700 - 18.9500
Volume361
Avg. Volume887
Market Cap3.415B
Beta0.62
PE Ratio (TTM)45.42
EPS (TTM)0.3770
Earnings DateN/A
Forward Dividend & Yield0.10 (0.56%)
Ex-Dividend Date2018-03-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • Abcam Plc : ABCZY-US: Dividend Analysis : November 17th, 2017 (record date) : By the numbers : November 17, 2017
    Capital Cube6 months ago

    Abcam Plc : ABCZY-US: Dividend Analysis : November 17th, 2017 (record date) : By the numbers : November 17, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Abcam Plc with the following peers – Bio-Techne Corporation, PerkinElmer, Inc., Shire PLC Sponsored ADR, Microbot Medical Inc, Thermo Fisher Scientific Inc., GW Pharmaceuticals PLC Sponsored ADR and Geron Corporation (TECH-US, PKI-US, SHPG-US, MBOT-US, TMO-US, GWPH-US and GERN-US). Abcam Plc’s dividend yield is 0.84 percent ... Read more (Read more...)

  • Abcam Plc :ABCZY-US: Earnings Analysis: For the six months ended June 30, 2017 : September 29, 2017
    Capital Cube8 months ago

    Abcam Plc :ABCZY-US: Earnings Analysis: For the six months ended June 30, 2017 : September 29, 2017

    Categories: Yahoo FinanceGet free summary analysis Abcam Plc reports financial results for the half-year ended June 30, 2017. Highlights Summary numbers: Revenues of USD 145.84 million, Net Earnings of USD 28.69 million. Gross margins widened from 65.92% to 66.08% compared to the same period last year, operating (EBITDA) margins now 30.44% from 34.67%. Change in operating cash ... Read more (Read more...)

  • We're sorry this is all we were able to find about this topic.